[{"id":"4746a5c7-6e18-41a2-aa58-47298afd30cd","acronym":"ISIKOK-19","url":"https://clinicaltrials.gov/study/NCT04206943","created_at":"2021-01-18T20:29:29.036Z","updated_at":"2024-07-02T16:36:50.891Z","phase":"Phase 1/2","brief_title":"Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL","source_id_and_acronym":"NCT04206943 - ISIKOK-19","lead_sponsor":"Acibadem University","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • ISIKOK-19"],"overall_status":"Unknown status","enrollment":" Enrollment 24","initiation":"Initiation: 10/12/2019","start_date":" 10/12/2019","primary_txt":" Primary completion: 01/01/2021","primary_completion_date":" 01/01/2021","study_txt":" Completion: 01/01/2021","study_completion_date":" 01/01/2021","last_update_posted":"2020-01-27"}]